Braden Millan

5PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 31, 2026
Long-Term Oncologic Outcomes of Neoadjuvant Tumor-Directed Immunotherapy (PROSTVAC) Before Radical Prostatectomy for Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Trial.

|Aug 26, 2026
Completion Nephrectomy Outcomes Following Prior Partial Nephrectomy in Hereditary Kidney Cancer Syndromes.

|Nov 16, 2025
Long-Term Follow-Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial.

Braden Millan, Nikhil Pramod, Ruben Blachman-Braun

|Aug 09, 2025
Top advances of the year: Bladder cancer.

Andrea B Apolo, Saad Atiq, Andre R Kydd

|Jun 10, 2022
A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results from the Canadian Kidney Cancer Information System.

Braden Millan, Rodney H Breau, Bimal Bhindi

Pageof 1

Frequent Collaborators

2 joint publications

Sandeep Gurram

1 joint publications

Andrea B Apolo

1 joint publications

Andre R Kydd

1 joint publications

Patrick D Michael